A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A post-hoc analysis of a 72-week...